Trade name
of Rovatineks®
the International unlicensed name
Is not present
the Dosage form
of the Capsule kishechnorastvorimy
Structure
One capsule contains
active agents: α-pinene of 24.8 mg, β-pinene of 6.2 mg, camphene of 15.0 mg,
baras camphor of 10.0 mg, p-propenyl anisole of 4.0 mg, fenchone of 4.0 mg, cineole of 3.0 mg,
excipient - olive oil,
structure of a cover of the capsule: gelatin, glycerin of 85%, sodium ethylparahydroxybenzoate (E 215), sodium propilparagidroksibenzoat (E 217), yellow sunset (E 110), quinolinic yellow 70% (E 104).
The description
the Spherical, soft, gelatin, kishechnorastvorimy capsules of yellow color containing chartreuse solution with a strong fragrant smell.
Pharmacotherapeutic group
Other drugs for treatment of urological diseases, including spasmolysants. Drugs for treatment of a nefrourolitiaz.
The ATX GO4BC code
the Pharmacological
Pharmacokinetics Terpenes properties which are present at the drug Rovatineks® are fat-soluble and are quickly soaked up. Terpenes, such as baras camphor, are significantly metabolized and removed with urine, generally in the form of glucuronides which increase solubility of salts of calcium (main components of renal and urinary stones).
The pharmacodynamics
of Rovatineks® promotes disintegration and elimination of stones from kidneys and urinary tract. The inhibiting effect of Rovatineksa® on forming of renal and urinary stones was established in a number of researches on animals. Роватинекс® has spasmolytic effect, promotes passing of stones on urinary tract, reduces pain in renal and ureteric gripes. Роватинекс® strengthens a renal blood stream and reduces the inflammatory phenomena.
Роватинекс® has antibacterial activity against a number of gram-positive and gram-negative microorganisms.
Indications
- for treatment of an urolithiasis
the Route of administration and doses
the Route of administration: inside.
The recommended dosing mode:
Adults: on 1 capsule from 3 to 4 times a day in 30 minutes prior to food.
Duration of a course of treatment is established by the doctor individually depending on a course of the disease.
Side effects
Insignificant number of patients noted slight and passing discomfort in a stomach. Vomiting was very seldom noted. In two cases the intolerance of drug was noticed (the reason is unknown).
Hypersensitivity
children's and teenage age up to 18 years
Medicinal interactions
of the Rovatineks® Capsule the patients accepting the anticoagulants or drugs which are metabolized in a liver and removed through a liver need to apply contraindications to drug components with care.
The special
instructions Rovatineks® it is not recommended to use for patients with the profound renal gripes, an anury or a heavy infection of urinary tract. In the course of treatment it is necessary to increase intake of liquid.
Drug contains excipients etilparagibroksibenzoat, propilparagidrokibenzoat which can cause allergic reactions (perhaps, the slowed-down type).
Pregnancy and the period of a lactation
the person has no data on use of drug during pregnancy. Animals have no data on teratogenecity of drug. However, at least, some of ingredients, can get through a placenta. Drug is not recommended to be used during pregnancy or feeding by a breast.
The feature of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms
is not available data on influence of the Rovatineks® capsules on these functions for patients.
Overdose
any case of overdose was Not registered.
In case of overdose if the drug was taken inside recently, it is necessary to carry out gastric lavage. If necessary observation should be combined with symptomatic treatment. Monitoring of warm, respiratory, renal and hepatic functions is recommended.
The form of release and packing
On 10 capsules place in blister strip packaging from a film of polyvinylchloride and aluminum foil.
On 5 or 10 packs together with the instruction for medical use in the state and Russian languages place in cardboard packing.
To Store storage conditions at a temperature not above 25 °C, in densely closed packing.
To store out of children's reach!
Not to use a period of storage of 5 years after an expiration date.
Prescription status
Without prescription
of Rovatineks®
the International unlicensed name
Is not present
the Dosage form
of the Capsule kishechnorastvorimy
Structure
One capsule contains
active agents: α-pinene of 24.8 mg, β-pinene of 6.2 mg, camphene of 15.0 mg,
baras camphor of 10.0 mg, p-propenyl anisole of 4.0 mg, fenchone of 4.0 mg, cineole of 3.0 mg,
excipient - olive oil,
structure of a cover of the capsule: gelatin, glycerin of 85%, sodium ethylparahydroxybenzoate (E 215), sodium propilparagidroksibenzoat (E 217), yellow sunset (E 110), quinolinic yellow 70% (E 104).
The description
the Spherical, soft, gelatin, kishechnorastvorimy capsules of yellow color containing chartreuse solution with a strong fragrant smell.
Pharmacotherapeutic group
Other drugs for treatment of urological diseases, including spasmolysants. Drugs for treatment of a nefrourolitiaz.
The ATX GO4BC code
the Pharmacological
Pharmacokinetics Terpenes properties which are present at the drug Rovatineks® are fat-soluble and are quickly soaked up. Terpenes, such as baras camphor, are significantly metabolized and removed with urine, generally in the form of glucuronides which increase solubility of salts of calcium (main components of renal and urinary stones).
The pharmacodynamics
of Rovatineks® promotes disintegration and elimination of stones from kidneys and urinary tract. The inhibiting effect of Rovatineksa® on forming of renal and urinary stones was established in a number of researches on animals. Роватинекс® has spasmolytic effect, promotes passing of stones on urinary tract, reduces pain in renal and ureteric gripes. Роватинекс® strengthens a renal blood stream and reduces the inflammatory phenomena.
Роватинекс® has antibacterial activity against a number of gram-positive and gram-negative microorganisms.
Indications
- for treatment of an urolithiasis
the Route of administration and doses
the Route of administration: inside.
The recommended dosing mode:
Adults: on 1 capsule from 3 to 4 times a day in 30 minutes prior to food.
Duration of a course of treatment is established by the doctor individually depending on a course of the disease.
Side effects
Insignificant number of patients noted slight and passing discomfort in a stomach. Vomiting was very seldom noted. In two cases the intolerance of drug was noticed (the reason is unknown).
Hypersensitivity
children's and teenage age up to 18 years
Medicinal interactions
of the Rovatineks® Capsule the patients accepting the anticoagulants or drugs which are metabolized in a liver and removed through a liver need to apply contraindications to drug components with care.
The special
instructions Rovatineks® it is not recommended to use for patients with the profound renal gripes, an anury or a heavy infection of urinary tract. In the course of treatment it is necessary to increase intake of liquid.
Drug contains excipients etilparagibroksibenzoat, propilparagidrokibenzoat which can cause allergic reactions (perhaps, the slowed-down type).
Pregnancy and the period of a lactation
the person has no data on use of drug during pregnancy. Animals have no data on teratogenecity of drug. However, at least, some of ingredients, can get through a placenta. Drug is not recommended to be used during pregnancy or feeding by a breast.
The feature of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms
is not available data on influence of the Rovatineks® capsules on these functions for patients.
Overdose
any case of overdose was Not registered.
In case of overdose if the drug was taken inside recently, it is necessary to carry out gastric lavage. If necessary observation should be combined with symptomatic treatment. Monitoring of warm, respiratory, renal and hepatic functions is recommended.
The form of release and packing
On 10 capsules place in blister strip packaging from a film of polyvinylchloride and aluminum foil.
On 5 or 10 packs together with the instruction for medical use in the state and Russian languages place in cardboard packing.
To Store storage conditions at a temperature not above 25 °C, in densely closed packing.
To store out of children's reach!
Not to use a period of storage of 5 years after an expiration date.
Prescription status
Without prescription
Related Products
